Don Berry

Don Berry, a pioneering Bayesian statistician with over 50 years of experience, joins his family members Nick and Lindsay Berry to discuss the fascinating evolution of Bayesian methods in clinical trials. They explore the ethical challenges of trial design, comparing patient treatment and learning. Lindsay shares insights from implementing adaptive trials during the COVID-19 pandemic, while Nick highlights the computational advancements of MCMC that made Bayesian modeling practical. Together, they delve into the future of Bayesian statistics, touching on its implications for AI and individualized medicine.